Karyopharm Therapeutics
KPTI
$1.10
Share price
3.77%
Change (1 day)
-71.43%
Change (1 year)
Categories
Karyopharm Therapeutics (KPTI) - Total assets
Total assets on the balance sheet as of December 2023 : $0.24 B
According to Karyopharm Therapeutics 's latest financial reports the company's total assets are $0.24 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Karyopharm Therapeutics - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.24 B | -32.87% |
| 2022-12-31 | $0.35 B | 17.32% |
| 2021-12-31 | $0.30 B | -2.47% |
| 2020-12-31 | $0.31 B | 6.13% |
| 2019-12-31 | $0.29 B | -13.55% |
| 2018-12-31 | $0.34 B | 89.24% |
| 2017-12-31 | $0.18 B | -0.05% |
| 2016-12-31 | $0.18 B | -16.27% |
| 2015-12-31 | $0.21 B | -2.22% |
| 2014-12-31 | $0.22 B | 39.25% |
| 2013-12-31 | $0.15 B | 11969.11% |
| 2012-12-31 | $1.31 M | -81.85% |
| 2011-12-31 | $7.22 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $73.21 B | 30,350.26% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 44,266.95% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 41,087.75% | 🇺🇸 USA |
 Exelixis EXEL | $2.94 B | 1,123.75% | 🇺🇸 USA |